ARCHIVES

New Treatment Modalities For Endometrial Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 3 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

February 27, 1987

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

New Data Support Claims That Costs Are Higher For Protocol Patients

August 31, 1984

NCAB Subcommittee Approves Compromise On Changes In Organ Site Program

April 9, 1982